Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center

The aim of the present study was to retrospectively evaluate response to therapy in 73 patients affected by systemic sclerosis (SSc) who underwent long-term cyclic treatment with intravenous iloprost for peripheral vascular involvement (average duration of treatment 54.12±41.04 months). Seventy-thre...

Full description

Bibliographic Details
Main Authors: A. Di Vita, M. Mosca, A. D'Ascanio, P. Pepe, A. Della Rossa, S. Casigliani Rabl, S. Bombardieri
Format: Article
Language:English
Published: PAGEPress Publications 2012-07-01
Series:Reumatismo
Subjects:
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/521